Lantheus Holdings, Inc.

Lantheus Holdings, Inc. - ROEverified

LNTH

Price:

$103.86

Market Cap:

$6.76B

Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium generator essential for nuclear medicine; Xenon-133, used to assess pulmonary function; Neurolite, which helps identify stroke-damaged areas in the brain;...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-06-25

Stock Exchange

NASDAQ

Ticker

LNTH

The ROE as of June 2026 (TTM) for Lantheus Holdings, Inc. (LNTH) is 24.33%

According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 24.33%. This represents a change of 306.08% compared to the average of 5.99% of the last 4 quarters.

Lantheus Holdings, Inc. (LNTH) Historical ROE (quarterly & annually)

How has LNTH ROE performed in the past?

The mean historical ROE of Lantheus Holdings, Inc. over the last ten years is 66.78%. The current 24.33% ROE has changed -63.57% with respect to the historical average. Over the past ten years (40 quarters), LNTH's ROE was at its highest in in the December 2017 quarter at 417.01%. The ROE was at its lowest in in the December 2022 quarter at -26.65%.

Quarterly (TTM)
Annual

Average

66.78%

Median

24.53%

Minimum

-25.12%

Maximum

529.75%

Lantheus Holdings, Inc. (LNTH) ROE by Quarter and Year

Discovering the peaks and valleys of Lantheus Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 537.85%

Maximum Annual ROE = 529.75%

Minimum Annual Increase = -2208.48%

Minimum Annual ROE = -25.12%

Quarterly (TTM)
Annual
YearROEChange
202521.43%-25.37%
202428.72%-28.27%
202340.04%537.85%
20226.28%-140.90%
2021-15.35%485.74%
2020-2.62%-109.48%
201927.63%-51.58%
201857.07%-89.23%
2017529.75%-2208.48%
2016-25.12%-415.70%

Lantheus Holdings, Inc. (LNTH) Average ROE

How has LNTH ROE performed in the past?

The current ROE of Lantheus Holdings, Inc. (LNTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

30.06%

5-year avg

16.22%

10-year avg

66.78%

Lantheus Holdings, Inc. (LNTH) ROE vs. Peers

How is LNTH’s ROE compared to its peers?

Lantheus Holdings, Inc.’s ROE is greater than Indivior Pharmaceuticals Inc (-142.01%), less than ACADIA Pharmaceuticals Inc. (35.65%), greater than Amneal Pharmaceuticals, Inc. (-144.72%), less than ADMA Biologics, Inc. (38.97%), greater than Supernus Pharmaceuticals, Inc. (-2.73%), greater than Praxis Precision Medicines, Inc. (-43.02%), less than HUTCHMED (China) Limited (37.04%), greater than Hinge Health, Inc. (-138.70%), less than Bausch Health Companies Inc. (120.75%), greater than Crinetics Pharmaceuticals, Inc. (-43.96%),

Build a custom stock screener for Lantheus Holdings, Inc. (LNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantheus Holdings, Inc. (LNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Lantheus Holdings, Inc.'s ROE?

How is the ROE calculated for Lantheus Holdings, Inc. (LNTH)?

What is the highest ROE for Lantheus Holdings, Inc. (LNTH)?

What is the 3-year average ROE for Lantheus Holdings, Inc. (LNTH)?

What is the 5-year average ROE for Lantheus Holdings, Inc. (LNTH)?

How does the current ROE for Lantheus Holdings, Inc. (LNTH) compare to its historical average?